NZ507836A - Crystalline [r*(r* ,r*)]-2-(4-flurophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) - Google Patents
Crystalline [r*(r* ,r*)]-2-(4-flurophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)Info
- Publication number
- NZ507836A NZ507836A NZ50783696A NZ50783696A NZ507836A NZ 507836 A NZ507836 A NZ 507836A NZ 50783696 A NZ50783696 A NZ 50783696A NZ 50783696 A NZ50783696 A NZ 50783696A NZ 507836 A NZ507836 A NZ 507836A
- Authority
- NZ
- New Zealand
- Prior art keywords
- flurophenyl
- atorvastatin
- phenylamino
- methylethyl
- pyrrole
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1136895A | 1995-07-17 | 1995-07-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ507836A true NZ507836A (en) | 2001-02-23 |
Family
ID=21750085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ50783696A NZ507836A (en) | 1995-07-17 | 1996-07-08 | Crystalline [r*(r* ,r*)]-2-(4-flurophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ507836A (en) |
-
1996
- 1996-07-08 NZ NZ50783696A patent/NZ507836A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1018052A1 (en) | Crystalline [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl)-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) | |
IL122161A0 (en) | Process for the production of amorphous [R-(R*,R*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3- phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1- heptanoic acid calcium salt (2:1) | |
IL158790A0 (en) | Crystalline forms of [r-(*,r*)]-2-(4-fluorophenyl) -beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt (2:1) (atorvastatin) | |
IL128863A0 (en) | Crystalline (R-(R*R*)-2-(4-fluorophenyl)-beta- delta-dihydroxy-5- (1-methylethyl)-3--phenyl-4- (phenylamino)carbonyl)-IH- pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) | |
NZ507836A (en) | Crystalline [r*(r* ,r*)]-2-(4-flurophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) | |
DE69616358D1 (en) | CRYSTALLINE FORM III OF THE HEMI CALCIUM SALTS OF [R- (R *, R *)] - 2- (4-FLUORPHENYL) -BETA-DELTA-DIHYDROXY-5- (1-METHYLETHYL) -3-PHENYL-4 - [( PHENYLAMINO) CARBONYL] -1H-PYRROL-1-HEPTANIC ACID (ATORVASTATIN) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
RENW | Renewal (renewal fees accepted) | ||
EXPY | Patent expired |